Related Experiment Videos
[Primary cardiac lymphoma]
C B Kragelund1, L Søndergaard, O W Bjerrum
1H:S Rigshospitalet, Hjertecentret, medicinsk kardiologisk afdeling B, og Finsencentret, medicinsk haematologisk afdeling L. ckss@dadlnet.dk
Ugeskrift for Laeger
|March 22, 2001
Summary
Primary cardiac non-Hodgkin lymphoma, though rare, has a good prognosis with early diagnosis. This case highlights a successful chemotherapy treatment leading to complete tumor regression in a patient with cardiac lymphoma.
Area of Science:
- Cardiology
- Oncology
- Hematology
Background:
- Primary cardiac non-Hodgkin lymphoma is an exceptionally rare malignancy.
- Early diagnosis is crucial for a favorable prognosis, despite non-specific symptoms.
- Diagnostic challenges include inconclusive clinical investigations.
Observation:
- A patient presented with severe dyspnea, chest pain, and fatigue.
- Electrocardiogram (ECG) revealed a complete atrioventricular block.
- Magnetic resonance imaging (MRI) identified a right atrial and ventricular tumor.
Findings:
- Myocardial biopsy confirmed diffuse, large B-cell type non-Hodgkin lymphoma.
- Chemotherapy was initiated as the treatment modality.
- Post-treatment MRI demonstrated complete tumor regression.
Implications:
- This case underscores the importance of considering rare cardiac tumors in differential diagnoses.
- Effective chemotherapy regimens can lead to complete remission in cardiac lymphoma.
- Advanced imaging like MRI is vital for diagnosis and treatment monitoring.